Snapshot 2013 webcasts
Did you miss the PACE 2013 Snapshot session held in Amsterdam? View the 3 minute webcasts with faculty members for a short overview
Webcast • Snapshot 2013
Webcast • Snapshot 2013
Webcast • Snapshot 2013
Webcast • Snapshot 2013
Webcast • Amsterdam, August 31, 2013
Webcast • Amsterdam, August 31, 2013
Webcast • Amsterdam, August 31, 2013

Options left for HDL therapies
Snapshot 2013 Prof. Bryan Brewer (Washington DC, USA) discusses the options left for HDL therapies to reduce the residual risk in statin therapy. What are the HDL therapies in active investigation?
Inflammation: targets for intervention
Snapshot 2013 Prof. Ulf Landmesser (University Hospital Zurich, CH) provides an overview of the targets for intervention in the inflammatory process in cardiovascular disease.
HoFH: Prevalence and new treatments
Dr. Kees Hovingh, Amsterdam, reviews recent data on the prevalence, phenotype and novel treatment options for patients with Homozygous Familial Hypercholesterolaemia
Targeting fasting and post-prandial triglycerides
Dr. Joanne Donovan, describes a potential novel approach to target fasting and post-prandial triglycerides with an oral agent that targets intestinal and liver PCSK9
Therapy resistant hypertension: novel pharmacotherapy or renal denervation?
Prof. Luis Ruilope about current options to manage therapy resistant hypertension.
Therapeutic innovations for severe hypertriglyceridemia
Prof. Daniel Gaudet reviews the effects of a new antisense-based therapy on the potential treatment of severe hypertriglyceridemia.
Share this page with your colleagues and friends: